Global Fuchs’ Endothelial Corneal Dystrophy Market, By Treatment (Medication, Surgery, Others), Diagnosis (Cornea Examination and Grading, Corneal Tomography, Corneal Pachymetry, Corneal Cell Count, Others), Symptoms (Sensitivity to Light, Night Vision Problems, Swelling, Inability to Drive at Night, Gritty-like Feeling in Both Eyes, Pain, Low Vision in Humid Weather, Cloudy Vision, Appearance of Halo-like Circles Around Lights, Others), Dosage (Solutions, Tablet, Injection, Others), Route of Administration (Oral, Topical, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.